Design and Synthesis of Organic Molecules for Anticancer Drug Development

@article{1722987,
      author = {Dr. K. S. Lamani},
      title = {Design and Synthesis of Organic Molecules for Anticancer Drug Development},
      journal = {Iconic Research And Engineering Journals},
      year = {2019},
      volume = {2},
      number = {8},
      pages = {375-384},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1722987.pdf},
      abstract = {Cancer is still one of the largest global health burdens due to the complex biology behind the process, uncontrolled proliferation of cells and mutations, as well as continuous and insistent needs to develop novel effective anticancer agents although established anticancer drugs made some notable success in cancer treatment. Many established chemotherapy drugs suffer from serious disadvantages like resistance development, lack of specificity toward tumor cell and normal cell, toxicity related with dosage, undesirable adverse effects and relatively low therapeutic index, therefore creating an imperative need for novel drugs and chemical entities with better physicochemical and pharmacokinetic properties. Organic molecules form a quintessential backbone for the development of medicinal chemistry today with its potential for structural variation, ability to participate in chemical transformations and to interact with particular cellular targets which in turn enable them as valuable molecular species to design selective anticancer agents, affecting the cellular pathways which were reported to be crucial in cancer promotion, survival and pathogenesis. This conceptual research article aims to present the systematic process of design and synthesis of novel organic molecules which has the potential to be used as novel anticancer agent using rational molecular design approaches, functionalization/modification of privileged structure and advanced organic synthesis approaches towards the identification of molecular features corresponding to an enhanced activity, selectivity and druglike properties. The presented strategy to design and synthesis novel cancer static entities comprises structural optimization via derivatization, heterocyclic moiety inclusion and molecular architecture modification as strategy to explore relation between molecular structure and anti-cancer activity and to identify beneficial groups for anti-cancer activity; The developed molecules were hypothetically suggested to have their structural elucidation using various Spectroscopic characterizations such as fourier transform infrared spectrum, Nuclear Magnetic Resonance spectrum and Mass spectroscopy while potential interaction with tumor related proteins was predicted with computational approach using docking; Moreover the molecular models were designed by applying a knowledge of relation between molecular structure and anti-cancer activity, which includes molecular modeling and QSAR prediction as well as ADMET analysis to have an idea of interactions between target molecules and predicted drug molecules and drug-like characters which is useful to identify promising lead compounds before the biological assay.},
      keywords = {Anticancer Drug Development, Organic Molecules, Medicinal Chemistry, Rational Molecular Design, Organic Synthesis, Structure–Activity Relationship (SAR)},
      month = {February},
  }